A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
Clinical trial NCT04529772 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04529772
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2027-02-22
- Enrollment
- 611
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.